作者:
Wilson,P.M. [1]
;
Yang,D. [2]
;
Azuma,M. [3]
;
Shi,M.M. [4]
;
Danenberg,K.D. [5]
;
Lebwohl,D. [6]
;
Sherrod,A. [7]
;
Ladner,R.D. [8]
;
Zhang,W. [9]
;
Danenberg,P.V. ;
Trarbach,T. ;
Folprecht,G. ;
Meinhardt,G. ;
Lenz,H.-J.
作者单位:
University Hospital Dresden, Dresden, Germany
[1]
Department of Preventive Medicine, University of Southern California/Norris Comprehensive Cancer
[2]
Response Genetics Inc., Los Angeles, CA, United States
[3]
Novartis Oncology, East Hanover, NJ, United States
[4]
Department of Molecular Biology and Biochemistry, University of Southern California/Norris
[5]
Department of Pathology, University of Southern California/Norris Comprehensive Cancer Center, Keck
[6]
University of Essen, West German Cancer Center, Essen, Germany
[7]
Global Clinical Development Oncology Bayer Healthcare Pharmaceuticals, Montville, NJ, United States
[8]
Division of Medical Oncology, University of Southern California/Norris Comprehensive Cancer Center
[9]
发布时间
2014-01-22